Home › Compare › ICHHF vs ABBV
ICHHF yields 6.32% · ABBV yields 3.06%● Live data
📍 ICHHF pulled ahead of the other in Year 1
Combined, ICHHF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ICHHF + ABBV for your $10,000?
Ichinen Holdings Co., Ltd. engages in automotive leasing, chemical, parking, machine tool sales, and synthetic resin businesses in Japan. It provides automobile leasing, fuel sales, and automotive maintenance and outsourcing services; and manufactures various chemical products to power, iron, and steel plants, as well as to repair shops and households. The company also operates parking lots and plots for facilities, such as supermarkets and hospitals, parking garages affiliated with tenant buildings, and idle lands; and offers automotive, industrial machine, air conditioning, and do-it-yourselfers tools. In addition, it manufactures and sells synthetic resins. The company was formerly known as Kuroda Shoji Co., Ltd. and changed its name to Ichinen Holdings Co., Ltd. in 2008. Ichinen Holdings Co., Ltd. was founded in 1930 and is headquartered in Osaka, Japan.
Full ICHHF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.